289 related articles for article (PubMed ID: 30197761)
1. Approaches to the discovery of non-invasive urinary biomarkers of prostate cancer.
Jedinak A; Loughlin KR; Moses MA
Oncotarget; 2018 Aug; 9(65):32534-32550. PubMed ID: 30197761
[TBL] [Abstract][Full Text] [Related]
2. Prostate-Specific Antigen (PSA) Screening and New Biomarkers for Prostate Cancer (PCa).
Stephan C; Rittenhouse H; Hu X; Cammann H; Jung K
EJIFCC; 2014 Apr; 25(1):55-78. PubMed ID: 27683457
[TBL] [Abstract][Full Text] [Related]
3. Prostate cancer proteomics: The urgent need for clinically validated biomarkers.
Evans CA; Glen A; Eaton CL; Larré S; Catto JW; Hamdy FC; Wright PC; Rehman I
Proteomics Clin Appl; 2009 Feb; 3(2):197-212. PubMed ID: 26238619
[TBL] [Abstract][Full Text] [Related]
4. Narrative review of urinary glycan biomarkers in prostate cancer.
Hatakeyama S; Yoneyama T; Tobisawa Y; Yamamoto H; Ohyama C
Transl Androl Urol; 2021 Apr; 10(4):1850-1864. PubMed ID: 33968674
[TBL] [Abstract][Full Text] [Related]
5. Combined serum and EPS-urine proteomic analysis using iTRAQ technology for discovery of potential prostate cancer biomarkers.
Zhang M; Chen L; Yuan Z; Yang Z; Li Y; Shan L; Yin B; Fei X; Miao J; Song Y
Discov Med; 2016 Nov; 22(122):281-295. PubMed ID: 28009970
[TBL] [Abstract][Full Text] [Related]
6. Detection of High-grade Prostate Cancer Using a Urinary Molecular Biomarker-Based Risk Score.
Van Neste L; Hendriks RJ; Dijkstra S; Trooskens G; Cornel EB; Jannink SA; de Jong H; Hessels D; Smit FP; Melchers WJ; Leyten GH; de Reijke TM; Vergunst H; Kil P; Knipscheer BC; Hulsbergen-van de Kaa CA; Mulders PF; van Oort IM; Van Criekinge W; Schalken JA
Eur Urol; 2016 Nov; 70(5):740-748. PubMed ID: 27108162
[TBL] [Abstract][Full Text] [Related]
7. Advances in proteomic prostate cancer biomarker discovery.
Goo YA; Goodlett DR
J Proteomics; 2010 Sep; 73(10):1839-50. PubMed ID: 20398807
[TBL] [Abstract][Full Text] [Related]
8. Urinary RNA-based biomarkers for prostate cancer detection.
Martignano F; Rossi L; Maugeri A; Gallà V; Conteduca V; De Giorgi U; Casadio V; Schepisi G
Clin Chim Acta; 2017 Oct; 473():96-105. PubMed ID: 28807541
[TBL] [Abstract][Full Text] [Related]
9. Urinary microRNA-based signature improves accuracy of detection of clinically relevant prostate cancer within the prostate-specific antigen grey zone.
Salido-Guadarrama AI; Morales-Montor JG; Rangel-Escareño C; Langley E; Peralta-Zaragoza O; Cruz Colin JL; Rodriguez-Dorantes M
Mol Med Rep; 2016 Jun; 13(6):4549-60. PubMed ID: 27081843
[TBL] [Abstract][Full Text] [Related]
10. Discovery and validation of urinary biomarkers for prostate cancer.
Theodorescu D; Schiffer E; Bauer HW; Douwes F; Eichhorn F; Polley R; Schmidt T; Schöfer W; Zürbig P; Good DM; Coon JJ; Mischak H
Proteomics Clin Appl; 2008 Mar; 2(4):556-570. PubMed ID: 19759844
[TBL] [Abstract][Full Text] [Related]
11. Using gene expression from urine sediment to diagnose prostate cancer: development of a new multiplex mRNA urine test and validation of current biomarkers.
Mengual L; Lozano JJ; Ingelmo-Torres M; Izquierdo L; Musquera M; Ribal MJ; Alcaraz A
BMC Cancer; 2016 Feb; 16():76. PubMed ID: 26856686
[TBL] [Abstract][Full Text] [Related]
12. Biomarkers in prostate cancer surveillance and screening: past, present, and future.
Cary KC; Cooperberg MR
Ther Adv Urol; 2013 Dec; 5(6):318-29. PubMed ID: 24294290
[TBL] [Abstract][Full Text] [Related]
13. Clinical Biofluid Assays for Prostate Cancer.
Borbiev T; Kohaar I; Petrovics G
Cancers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201592
[TBL] [Abstract][Full Text] [Related]
14. Prostate cancer biomarkers: an update.
Romero Otero J; Garcia Gomez B; Campos Juanatey F; Touijer KA
Urol Oncol; 2014 Apr; 32(3):252-60. PubMed ID: 24495450
[TBL] [Abstract][Full Text] [Related]
15. Blood-based and urinary prostate cancer biomarkers: a review and comparison of novel biomarkers for detection and treatment decisions.
Hendriks RJ; van Oort IM; Schalken JA
Prostate Cancer Prostatic Dis; 2017 Mar; 20(1):12-19. PubMed ID: 27922627
[TBL] [Abstract][Full Text] [Related]
16. Novel biomarkers and genomic tests in prostate cancer: a critical analysis.
Falzarano SM; Ferro M; Bollito E; Klein EA; Carrieri G; Magi-Galluzzi C
Minerva Urol Nefrol; 2015 Sep; 67(3):211-31. PubMed ID: 26054411
[TBL] [Abstract][Full Text] [Related]
17. Urinary exosomal shuttle RNA: Promising cancer diagnosis biomarkers of lower urinary tract.
De Palma G; Di Lorenzo VF; Krol S; Paradiso AV
Int J Biol Markers; 2019 Jun; 34(2):101-107. PubMed ID: 30862241
[TBL] [Abstract][Full Text] [Related]
18. New circulating biomarkers for prostate cancer.
Bensalah K; Lotan Y; Karam JA; Shariat SF
Prostate Cancer Prostatic Dis; 2008; 11(2):112-20. PubMed ID: 17998918
[TBL] [Abstract][Full Text] [Related]
19. [Urinary biomarkers in prostate cancer: an update].
Durand X; Xylinas E; Ploussard G; De la Taille A
Prog Urol; 2010 Dec; 20(13):1184-91. PubMed ID: 21130396
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
